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Antithrombotic activity of the glomerular basement membrane (GBM)
of the rat kidney is dependent on glomerular ADP-ase activity. W. W.
Bakker, E.J. Willink, M.J. Hardonk, Department of Pathology, Uni-
versity of Groningen, Groningen, The Netherlands. Recently the activ-
ity of nucleoside polyphosphatases, including ADP-ase, has been
demonstrated in situ throughout the GBM of the normal rat kidney
using cytochemical methods at the ultrastructural level. To investigate
the possible influence of glomerular ADP-ase activity upon experimen-
tally—induced intraglomerular platelet aggregation, we carried out alter-
nate perfusion experiments with human platelets and ADP in rat
kidneys ex vivo, taking advantage of previous results showing that
either injection of adriamycin (ADR) (7.5 mg/kg body wt) or local
X-irradiation (Xirr, 2000 rads) reduces glomerular phosphatase activity,
whereas injection of an other nephrotoxic drug, that is,
aminonucleoside of puromycin (PAN) (15 mg/kg body wt) does not
affect this enzyme activity. Kidneys of inbred PVG rats 24 hr after
treatment with either ADR (N = 5); PAN (N = 4), or Xirr (n = 3) or
untreated rats (N 6), were perfused cx vivo with buffered saline (PBS)
37°C, pH 7.2, to remove blood and subsequently with 4 ml PBS
containing 1 j.g/ml endotoxin to facilitate intraglomerular platelet
accumulation. Subsequently, alternate perfusion (flow rate 2 mI/mm)
with 4 ml human platelet—rich plasma (PRP) (9 x l0 platelets/mi) was
followed by 4 ml ADP (10 j.g/ml) in PBS, and again 4 ml PRP was
carried out. Kidneys were taken out and processed for light (LM),
immunofluorescence (IF) and electron microscopy (EM). The results
show intraglomerular platelet aggregation in about 50% of the glomeruli
of both ADR as well as Xirr rats, in contrast to PAN-treated or normal
rats in which no platelet aggregation could be detected using LM. Using
EM and IF accumulation of activated platelets and deposition of
products from activated platelet, that is, platelet factor 4 and /3-
thromboglobulin, could be detected along the GBM exclusively in
kidneys of ADR treated or Xirr rats. Since glomerular ADP-ase
activity, in contrast to other putative antithrombotic molecules in the
GBM, that is, heparan sulphate proteoglycans, is clearly affected by
ADR treatment or X-irradiaton, it is concluded that the activity of
glomerular ADP-ase may reflect an important antithrombotic principle
in the GBM of the rat kidney.
The role of complement in the heterologous phase of anti-GBM
nephritis in the mouse. G. Schrijver, K.J.M. Assmann, M.J.J.T.
Bogman, R.A.P. Koene Dep. of Pathology and Dep. of Medicine, Div.
of Nephrology, Si. Radboud Hospital, University of Nijmegen,
Nmegen, The Netherlands. Anti-GBM nephritis was induced in
B10.D2 mice by injection of heterologous antibodies against mouse
GBM. Histologically, the glonseruli showed linear deposits of the
injected antibody along the GBM together with granular deposition of
C3, intravascular influx of polymorphonuclear granulocytes (PMNs),
and deposition of fibrin. This heterologous phase was accompanied by
a dose dependent albuminuria. When a low dose of antibody was
injected into congenic mice with a complete congenital deficiency of
complement factor CS (Bl0.D2/old) the albuminuria was greatly re-
duced. However, when the antibody dose was raised, the reduction in
albuminuria was less pronounced.
.
Antibody Dose
(mg)
Albuminuria(g/ SD at day I18 hr)
PB10.D2/new BlO.D2/old
1.9 1252 466 531 196 <0.0007
7.5 8895 4011 4127 1909 NS
Comparable results were found in B10.D2/new mice made completely
deficient 01 C3 by Cobra Venom Factor (CVF) treatment. Despite the
complete absence of C3 deposits in the glomeruli of the CVF-treated
mice, the PMN influx in the glomeruli was similar to that seen in
complement—normal B10.D2/new mice, reaching a maximum at two
hours after injection of the antibody. Deposition of fibrin was first
present at two hours and increased thereafter both in complement—
normal and complement—deficient mice. We conclude that in this
model there are at least two pathways leading to albuminuria, one of
which is complement—dependent. The mediator system of the
complement—independent pathway is unclear. PMNs invading the
glomeruli despite the complement depletion may release mediators that
increase the permeability of the capillary wall. Intravascular coagula-
tion may also play a role.
Follow-up of renal function and proteinuria in rats with a reduced
number of nephrons on various protein diets. M.H. Dc Ke/jzer, A.P.
Provoost, ED. Wolff, andJ.C. Molenaar. Depts. of Pediatric Surgery
and Pediatrics, Erasmus University, Rotterdam, The Netherlands. A
reduction in the number of functioning nephrons may in the long run
lead to the development of end stage renal failure. This process may be
attenuated by a reduction in the daily protein intake. In rats, we wanted
to establish the degree of reduction in function initiating this process
and study the long—term effects of various protein intakes on the
glomerular filtration rate (GFR) and the urinary protein excretion
(UprotV). Nine experimental groups, initially consisting of 17 to 24 rats
were studied. In three—weeks—old male Wistar rats we applied three
types of operations: sham operation (2K), unilaterally nephrectomy
(NX), and a temporary ureteral obstruction plus removal of the contra-
lateral intact kidney (UO). Three diets were used, containing either
12%, 24%, or 36% of protein. The GFR, as the plasma clearance of
51-Cr EDTA, and the UprotV were determined every three months. The
follow up time is now 18 months, that is, about half of the expected
lifetime. The data on the GFR (mi/mm) and UprotV (mg/24h) are given at
3, 12, and 18 months. The data are expressed as a % of the 2K rats on
the 24% protein diet at three months.
GFR ml mm'
3 months
RAT: 12% 24% 36%
12
12%
months
24% 36%
18 months
12% 24% 36% diet
2K: 92 100 108
NX: 63 77 82
UO: 56 59 60
97
70
35
105
81
22
128
69
6
100
71
14
108
55
NS
117
32
NS
UprotV mg 24 hr'
2K: 108 100 151 58
NX: 103 149 268 249
LIft 248 370 573 997
NS = no surviving animals
89
552
1342
257
942
1723
49
277
1075
132
837
NS
257
933
NS
631
632 Ah,stroc't.s
The results indicate that in 2K rats, up to 18 months, the daily protein
intake did not adversely affect the GFR. On a high protein diet 2K rats
showed an increase in tiproV. In NX rats, the GFR deteriorated with
time on both the 24% and 36% protein diet. The fall in GFR occurred
earlier on the 36% protein diet, and was preceeded by a rise in UV.
The NX rats on a lnw protein diet showed no fall in GFR, but U ,0tV
was increased compared that of 2K rats on the same diet. The most
dramatic effects were noted in the UO rats. At three months, the GFR
was over 75% of that of NX rats on the same diet. The U 0V was
already markedly increased. On all three diets GFR fell rapidly, the
highest rate on the 36% and the lowest rate on the 12% protein diet. At
18 months there were no survivors in the groups of UO rats on a normal
and high protein diet. We conclude that in rats with a slightly damaged
siugic kidney a low protein diets delays, but not prevents, the devel-
opment of end stage renal failure.
The technique of the isolated perfused rahhit tuhule (IPRT) and its use
in exploring pharmacokinetics of indomethacin. I). de Zeeoa', HR.
Jacobson, and DC'. Bra/er, University Hospital, Groninpen, The
Netherlands, and (JTHSC at Dallas, USA. Renal secretion of drugs via
the tubular organic anion transporter has been studied by various in
vitro and in vivo techniques. All have their limitations. The IPRT has
the qualities and thereby offers opportunities that allow further charac-
terization of the organic anion transport system(s). The relevant tubule
segment, that is, the broxinsal straight tubule is dissected free hand from
a rabbit kidney slice. The tubule is transferred to a microperfusion
set—up consisting of a transmission microscope fitted with steady
supports at both sides. These enable mieromanipulation of concentric
glass pipets that will hold the tubule, The tubule is bathed in a flowing
bath solution at 38°C. The proximal end of the tubule is eanulated with
a glass pipet ahd perfused with an ultrafiltrate—like solution. The distal
end is sucked into a holding pipet allowing perfused fluid collection.
Samples are taken using a constant—volunie pipet. Tubular quality and
viability control is carried out by measurement of the transepithelial
voltage, and by a measurement of water reabsorption along the tubule
(J) using 4H-inulin as a marker. We developed a highly sensitive
HPLC-assay for indomethacin measurement (as low as 10 pg). This
allowed measurement of native (non-labeled) drug in the very small
collected saFnples (100 nI). Thus indomethacin transport from bath to
lumeli (Jind) could be estimated using close to pharmacological indo-
methacin bath concentrations (JtY6M). A series of 33 experiments with
varying concentrations of indomethacin in the bath fluid disclosed that
1aw obeys laws of saturable kinetics (V11 115 x It) 5Nm/mm/min, K,
— 6 x 10 6M). Cooling of the tubule to 18°C reduced J, from 0.39 0.06
to —0.02 0.01 nI/mm/mm. whereas in5 was inhibited only by 52 5%
(N -° 12). Moreover, ouahain and the use of sodium—free solutions also
reduced nd to half of control values (N 6). This strongly suggests that
inS is partly mediated by a secondary active sodium coupled trans-
porter. Probenecid and PAH at different concentrations showed a
competitive inhibition of (N 10). Both compounds were able to
completely abolish nd (10%m bath) at bath concentrations of 2 x
105M probenecid and 2 x 103M PAl-I. Furthermore, the disulfonate
stilbene DIDS (an anion exchange inhibitor) inhibited 3jnd of the cooled
tubule to zero (N = 8). In conclusion, the IPRT is a technique suited for
studyiog renal secretion of drugs. Indomethacin is excreted into the
lumen of the rabbit proximal straight tubule. 'the affinity of indometh-
acm for the carrier is higher than that of probenecid and PAH. At least
half of the transport is active. The remaining passive component is
inhibited by probenecid and DIDS, suggesting the presence of an anion
exchanger for indomethacin transport.
Sensitivity of screening methods for renovascular hypertension can be
improved: First experiences with a new animal model. 0..!. .Jonker, D. c/c
Zeeumv. JIM. Hui.sman, f/K. vcin der Hem, Deportoient of Nephrol—
04)', State University Groom pen. (Ironinge,m, '1'tic' Netherlands. Diag-
nosis of renovascular hypertension is l'requently hanipered by
false—negative rapid—sequence IVU (rs-IVU) or renography (RE). Prob-
ably in these eases the presence of renal artery stenosis is obscured by
renal autoregulation. The latter is critically dependent upon the
rcnin—angiotensin and the prostaglandin systems. We developed an
animal model to answer the question whether drugs blocking these
systems will decrease autoregulatory capacity to such an extent that the
sensitivity of rs-IVU and RE as screening methods is enhanced. As a
model, the salt—depleted chronically—instrumented conscious dog was
chosen. 'l'he instrumentation consists of permanent arterial and venous
catheterization. elccti'oniagnetic flow probes around both renal arteries
and a newly developed constrictor device around one of the renal
arteries. This constrictor is externally adjustable viaa hydraulic mech-
anism and the applied constriction remains stable through a mechanical
catch. Furthermore, a new method was evaluated to obtain a reference
zero (no blood flow) value for the electromagnetic blood flow measure-
ment. Pharmacologically obtained diastolic zero flow by intra-aortic
injection of angiotcnsin Ii compared favorably with a mechanical
occlusion, and it appeared to he an easily reproducible method. In this
model, data before and after renal artery constriction were compared.
After a recovery period of two to three weeks, control rs-IVU and
23lhippuran RE were perlhrmed before and after intravenous admin-
istration of to mg enalaprilic acid (MK-422). Blood pressure and renal
blood flow were registered before and during both procedures. Various
degrees of stenosis were made, and two to three weeks later the
"diagnostic" measurements were repeated. Four dogs have presently
finished this protocol. In the control period no differences between the
two kidneys were observed. 'l'he outcome of these measurements did
not change after MK-422 injection. Interestingly, following mild to
moderate stenosis (that is, 25 to 60% flow reduction), rs-IVU as well as
RE showed no or only slight differences between the post-stenotic and
the contralatcral kidney. However, after MK-422 there were marked
differences between the two kidneys. Thus. preliminary results of this
new model to study renal artery stenosis in the conscious dog indicate
that the sensitivity of both rs-IVU and RE can he improved by acute
converting enzyme inhibition.
Inhibition of drug protein binding (PB) in uremia. R. Von/molder, N.
Van Loridsc'hoot, R. Dc Sinet, .S'. Rio goir, Renal Divfsion, University
Hospital, 9000 Ghent, Belghon. The influence of renal failure on protein
binding (PB) of several drugs was evaluated by an ultrafiltration
method. The study was performed in normal serum, serum of patients
with moderate and pronounced chronic renal failure (serum ereatinine
C 1.3, 3 to 6 and > 6 mg/dl. respectively) and serum of patients under
hemodialysis treatment. No significant changes were i'cgistered for
cimetidine and imipramine. A progressive decrease in PB related to the
degree of renal failure was observed for diazepam, theophylline,
metlmotrexate, phenytoine, and prazosine. The alterations were most
pronounced for theophylline (from 64.7 0.5 in healthy controls to 43.5
4.1 % in dialyzed patients), methotrexate (from 47.9 3.3 to 27.4
2.3 %) and phenytoine (from 91.6 0.2 to 75.6 2.9 9/') (P C 0.001).
1-lemodialysis caused no major changes in PB of all drugs under study.
Ultrafiltrate, obtained during a hemoliltration session, inhibited PB of
theophylline and phenytoin in a dose—dependent way. After separation
with high performance liquid chromatography (HPLC), it appeared that
at least a part of this inhibitory activity corresponded to the elution zone
of hippurate. Also this inhibition was dose-dependent. Hippuric acid
solution inhibited PB of theophylline and phenytoine in direct relation-
ship to its concentration. In conclusion, PB of several drugs is affected
during renal failure, which might influence their therapeutic effective-
ness. Hippurie acid is one of the uremic salutes playing a role in this
process.
EDTA Lead—mobilization test and bone lead concentration in occult
lead intoxication. R. I)oelemans, (1. Eestermans, P. D'Hoese, FL. Van
de Vym'er, P. Zaclmhe, R.L. Lias, GA. Verpooten, R.P. Weeden, ME.
Dc Broe. AZ. Stuis'ermberg, University Hospital A ntwerp, Antsverpen,
Belgiuom. In 35 patients (pat.), suspected of occult lead (Pb) intoxica-
tion, an EDTA Pb-mobilization test was performed by intramsmuscular
injections of 2 x I g CaNa EDTA, 8 hours (hr) apart. Urinary Ph
excretion (UPb) was measured by electrothermal atomic absorption
speetrometry (EAAS) in 24 hr urine samples in pat. with a serum
creatinine (se) C 1.5 mg/dI and extended to 72 hr when se > 1.5 mg/dI.
The test was considered positive if I.JPb > 1000 Mg, negative if EITh
601) Mg and inconclusive when 600 tg C liPh C 000 gig. 16 pat. (46%:)
had a mean UPb of 1852 Mg (1095—3700) (group 1), 14 pat. (40%) a mean
tiPb of 344 zg (160—517) (group 11). and 5 pat. (14%') a mean UPh of 753
Mg (671—870) (group III). There was no significant difference in renal
function in the 3 groups. Blood lead concentration (BPh), free erythro-
eyte protoporphyrin (PEP) and urinary delta-AEA were below interna-
tionally accepted standards in all pat. Transiliac bone biopsies were
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performed in 7 pat. of group 1 and 6 pat. of group II. Bone lead
concentration (BLC) determined by EAAS after destruction with nitric
acid, was respectively 26 ppm (14.5—33) in group I and 4 ppm (2.1—6.7)
in group II. There is a significant correlation (r = 0.94) between BLC
and UPb. BLC = 1.24 + 0.01267 UPb. Conclusion:
1. 46% of pat. suspected of occult Pb intoxication had a positive
EDTA test.
2. BPb, FEP and delta-ALA are of no value in this setting.
3. A positive EDTA test is indicative of excessive body Pb burden as
measured by transiliac BLC.
Causes and prognosis of acute renal failure (ARF) in the elderly. N.
Lameire, E. Matthys, R. Vanho/der, S. Ringoir, Gent, Belgium. The
question of old age as a negative prognostic factor in the outcome of
ARF is still controversial. Therefore, a retrospective analysis of the
causes and diagnostic and prognostic parameters of ARF was made
over the years 1980—1985 in one single renal unit, where all cases were
treated in a similar aggressive way. One hundred patients older than 65
years (Group I) were compared with 187 younger patients (Group II).
There was a higher incidence of postrenal ARF (9 vs. 4.8%), thrombo-
embolic diseases (8 vs. 1.6%) and hypovolemic ATN (19 vs. 9%) in
Group I, while non-oliguric ARF (19 vs. 38%), acute glomerulonephritis
(5 vs. 11%) and pigment—induced ARF(4 vs. 12.8%) were less frequent
in this group. An analysis of the diagnostic value of the urinary
parameters (RFI & FENa) revealed that in Group 1 21% and in Group II
15% of the values indicated prerenal ARF; this diagnosis could not be
accepted on clinical and/or histological grounds. Prognosis in both
groups was mainly related to the number of complications arising during
hospitalization. In Group I, the presence of initial hypokalemia and
metabolic alkalosis was associated with a very high mortality (>70%).
The overall mortality, however, was the same in both groups (46% in
Group I vs. 44% in Group 11). There was no correlation between
mortality and the applied dialysis strategy (acute peritoneal dialysis or
hemodialysis). In conclusion, the prognosis of ARF is independent of
age, and elderly patients with ARF should be treated in the same
aggressive way as younger patients.
Adrenergic vasoconstriction in the human hypertensive kidney: Over-
riding role of alpha-2 adrenoceptors. P.W. de Leeuw, P.N. van Es, P.
Vermey, W.H. Birkenhager. Department of Medicine, Zuiderzieken-
huis, Rotterdam, and Department of Pharmacy, University Hospital,
Leiden, The Netherlands. Adrenergic vasoconstriction contributes to
the elevation of renal vascular resistance in essential hypertension, but
it is not well known which type of alpha—adrenoceptors is involved in
this process. Therefore, we infused either the alpha-i antagonist
doxazosin (N = 7) or the alpha = 2 antagonist yohimbine (N = 7) into
the renal artery of hypertensive subjects immediately prior to diagnostic
angiography. Doxazosin was administered at incremental doses of 0.3,
1, and 3 ng kg min and yohimbine at doses of 1, 3, and 10 ng kg--I
min'. Each dose was given for five minutes; a group of six patients in
whom only vehicle was infused, served as a control group. Before the
infusions and at the end of each dose intra-arterial blood pressure and
mean renal blood flow (Xenon—washout) were measured. Doxazosin
increased renal perfusion without changes in blood pressure at doses of
0.3 and I ng kg min', with the highest dose systemic effects occurred
leading to a fall in blood pressure. Yohimbine also increased renal flow
without changes in pressure at doses of 1 and 3 ng kg-I min, but
reduced perfusion and increased blood pressure at the highest dose. At
the intermediate doses, doxazosin increased renal blood flow from 342
36 to 380 45 ml min' per 100 g (P < 0.05) while yohimbine
enhanced flow from 318 41(0500 62 mlmin' per 100 g(P <0.01).
The increment in flow produced by yohimbine greatly exceeded that
caused by doxazosin (P < 0.05). It is concluded that for a given level of
blood pressure prevailing sympathetic activity elevates vascular tone in
the kidney predominantly through alpha-2 adrenoceptors.
Mononuclear blood cells from patients with minimal change nephrotic
syndrome (MCNS) induce increased glomerular permeability in the rat
kidney in vivo. W.W. Bakker, J. BaIler, W.H.J. van Luyk, G.K. van der
Hem, Departments of Pathology, Pediatrics and Internal Medicine,
University Hospital Groningen, Groningen, The Netherlands. Periph-
eral mononuclear blood cells (PBC) from nephrotic and control subjects
were isolated to investigate their capacity to induce increased glomer-
ular permeability in viva in the rat kidney. Blood was taken from
untreated subjects with MCNS in relapse (selective proteinuria > 3 5
g/24 hr; N = 4) and in remission under corticosteroid treatment. In
addition, untreated subjects with non-selective proteinuria due to other
forms of nephropathy (N = 5) and healthy donors (N = 5) were studied.
Individual cell suspensions (20 x 106/3 ml per 150 g body wt) in buffered
saline were infused in the cannulated tail vein of anesthesized inbred
PVG rats using a constant infusion pump at a flow rate of 0.2 ml/min
followed by 2 ml anionic ferritin (76 mg/ISO g body wt). After an
additional period of 15 minutes, the animals were sacrificed and their
kidneys prepared for transmission electron microscopy (EM). The
localization of ferritin particles in the glomerular filtration barrier was
evaluated semiquantitatively in capillary loops of six glomeruli per
kidney. The results can be summarized as follows: exclusively in rats,
which had been infused with cells from MCNS subjects in relapse,
ferritin particles could be detected in the lamina rara interna (LRI),
lamina densa (LD), lamina rara externa (LRE), and between foot
processes at several sites along the capillary loops studied. In contrast,
neither following infusion of PBC from the same MCNS subjects in
remission nor from other subjects studied penetration of ferritin parti-
cles into the LD, LRE or urinary space could be observed. Localization
of ferritin was confined in these cases to the LRI of the filtration barrier.
It is suggested from the present data that PBC from nephrotic patients
with MCN S are able to change glomerular permeability in the rat kidney
in vivo. In view of the current idea of a circulating "factor" in the
pathogenesis of proteinuria in this disorder, the possibility emerges that
a circulating PBC subset may be a likely candidate for such a putative
factor in MCNS.
Tubular sodium (Na)-handling during mineralocorticoid escape (ME):
An analysis using free water and lithium clearance. W.H. Boer, HA.
Koomans, E.J. Dorhout Mees, Department of Nephrology, University
Hospital, Utrecht, The Netherlands. The established technique to
study tubular Na handling inman is the maximal free water clearance.
Using this technique, ME has previously been shown to result from a
rise GFR and a decrease in fractional proximal reabsorption (FPR). The
model of ME was chosen to test lithium (Li) as a quantitative marker of
proximal Na reabsorption. Simultaneous free water (C-H2O) and Li
clearances (C-Li) were performed in eight normal men prior to and after
six days of fludrocortisone acetate, when all had escaped from its Na
retaining effect. FPR was calculated from C-H20 as well as C-Li
(FPR-H2O and FPR-Li, respectively). All changes were significant (P <
0.001).
GFR C-H20 C-Li FPR-H20 FPR-Li
Control 125 mI/rn 15 ml/m 42 mI/rn 85.7% 67.5%
Escape 149 ml/m 24 mI/rn 76 mI/rn 81.3% 49.7%
As shown, the Li-method yields much lower control values for FPR
than the conventional method. It confirms that FPR is depressed during
ME, but the observed fall (18%) is much more pronounced than
obtained by the C-H20 method (4%). Consequently, distal Na delivery
increases from 5.8 to 11.1 mmol/min as compared to a change from 2.5
to 3.9 mmol/min calculated from C-H20. We suggest that the values
obtained by the Li-method are closer to reality, the differences between
both methods being mainly due to H2O backdiffusion, even during
maximal ADH suppression.
Aluminum levels, desferrioxamine tests and aluminum bone deposits in
a chronic hemodialysis population. R.M. Valentijn, J. W. de Fyter,
V.E.F. Papapoulos, Department of Nephrology and Pathology, Uni-
versity Hospital, Leiden. in a chronic hemodialysis population the
incidence of elevated aluminum levels, the response to desferrioxamine
(DFO) stimulation and the occurrence of bone aluminum deposits were
studied. In addition, the results were related to hormonal or histological
parathyroid activity. In 40 patients, 425 aluminum levels were deter-
mined at regular intervals during a two year follow—up. In 14 patients,
aluminum levels were < 80 pg/liter at all times, and in 16 patients
increased levels were found during 48 episodes. During eight episodes
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(six patients) the aluminum levels were > 200 jig/liter. No relation with
MCV, Ca, P04, alkaline fosfatase or ferritine could be found. DFO-
stimulation tests (20 mg DFO/kg body wt i.v.) were performed in 30
patients. An abnormal response to DFO was noted in ten cases. In eight
of these cases the baseline aluminum levels before DFO-testing was C
100 pg/liter. Aluminum bone deposits were found in II of 18 bone
biopsies, and in six of the II cases an abnormal DFO-test was fonnd,
while the DFO-test was also abnormal in three of the seven cases
without bone aluminum deposits. The relationships with parathyroid
status showed the following: six of the eight episodes with baseline
aluminum levels > 200 jig/liter occurred in patients with a recent (mean
15.5 months) parathyreoidectomy (PTX); an abnormal DFO-tcst was
mainly found in patients with active hyperparathyreoidism based on
i-PTH levels (N = 6) or bone histology (N 5); six of the seven patients
with a recent PTX had positive aluminum bone deposits; the A
aluminum after DFO was correlated with the PTH level. In patients
with PTI-1 levels 3 the A aluminum was 146 87 jig/liter, while in
patients with PTH levels > 13 the aluminum was 296 150 jig/liter
whde in both groops aluminum bone deposits were present. Iu conclu-
sion we found that: baseline aluminum levels are frequently elevated in
a chronic hemodialysis population; DFO-stimulation tests provide
useful information, also in eases with low baseline aluminum levels; the
response to DFO-stimutation is correlated with parathyreoid activity,
and after successful PTX a high incidence of aluminum bone deposits is
found.
Late conversion from cyclosporin to azathioprine one year after
cadaveric renal transplantation. D.J. Verslois, FilM. Derkx, G.J.
Wenting, M.A.D.H. Scholekamp, W. Weimor, Deportment of Internal
Medicine I, University hospital Rotterdam—Djjkzigt, Rotterdom, The
Netherlands. The results of organ transplantation have significantly
improved after the introduction of cyclosporin A (CsA). Unfortunately
CsA is nephrotoxic and could lead to irreversible and progressive
nephropathy. To avoid these long term sequelae conversion from CsA
to azathiopriuc (AZA) has been suggested. Several studies indeed
showed an improvement of renal function after stopping CsA at three or
six months after transplantation. However, these early conversions
resulted in a high incidence of allograft rejection. In an attempt to
induce a safer engraftment, we continued CsA therapy for one year in
23 cadaveric renal allograft recipients before switching to AZA. CsA
was stopped and AZA (2 mg/kg) was introduced the next day. All other
medication, including 10 to IS mg prednisone was continued. Within
three months after conversion five of 23 patients showed acute rejec-
tion; four of five were recipients of second grafts (P < 0.01); two of five
lost their graft. One of 23 had recurrence of primary disease. In the
remaining 17 successfully converted patients we studied the
reversibility of CsA toxicity. Three months after conversion ERPF (131j
Hippurate) had increased from 216 to 250 mI/mm and GFR (1251
Thalamate) from 65 to 72 mI/mm. Serum creatininc dropped from 160 to
128 jzmol/l, while creatiuioe clearance improved from 46 to 59 mI/mm.
Blood pressure (DatascopeR) decreased in all 17 patients: 140/91 to
119/77; renin levels increased from 10.7 to 16.7 jiU/ml. All these
changes were highly significant (P <0.01). We also observed that serum
cholesterol signiticantly fell from 7.8 to 6.2 mmol/liter with a concom-
itant decrease in triglycerides from 2.80 to 2.18 mmol/liter. The two
hours glucose levels after oral OTT also significantly dropped from 6.7
to 5.0 mmol/liter. '1he reversibility of nephrotoxic and metabolic side
effects of CsA after one year of continuous therapy suggests that no
permanent structural damage had developed, which refutes a main
argument for conversion. Moreover, the risk of rejection following
conversion still remains high even after one year of CsA therapy
especially in recipients of second allografts.
Renal tubular fnnction in amyloidosis. S. Jonssen, S. Mci/er, D.,4.
Piers, M.H. van Ri/s wi/k, U.K. von der Hem, Deportment qf Medicine,
University Hospital, Groningen, The Netherlands. Renal involvement
is a major cause of morbidity in patients with amytoidosis. Histological
studies indicate that renal failure might develop nut mainly as the result
of glomerular, but as the consequence of vascular amyluid deposition,
resulting in interstitial fibrosis wih concomitant tubular atrophy. This
would imply that tubular function is inipaired in renal amyloidosis and
that measuremeot of the degree of tubular dysfunction might provide
information on the degree of interstitial fibrosis. To test this hypothesis
we studied tubular function on 35 occasions in 22 patients with
biopsy—proven renal amyloidosis. Proximal tubular function was mea-
sured by the relative clearance of 99"Te-dimercaptosuecinatc
(RelClssmTeDMSA) using a continuous infusing technique with simul-
taneous determination of the glomerular liltratiuu rate (GFR) using the
clearance of '51-iothalamate; the relative clearance of ssmTcDMSA is
expressed as the s9mTeDMSA to the i2SUiothalamate clearance x 100%
(normal value 16%). The degree of interstitial fibrosis in renal
biopsies was estimated semiquantitatively. Fifteen patients with
nonamyloidotie glomerular diseases served as controls. There was no
difference in GFR between the controls and the amyloid patients. The
RelClSmFcDMSA was less than 16% in the controls irrespective of the
degree of renal function loss measured by the GFR, whereas in amyloid
nephropathy the RelClssmTcDMSA was elevated in 86%. Our results
indicate that proximal tubular dysfunction is a frequent finding in renal
amyloidosis and that an increased filtered load (OFR x serum
DMSA activity) does not contribute to an increased urinary excretion of
99"Tc-DMSA. In the amyluid patients there appeared to be a negative
correlation between GFR and RelClssmTeDMSA (r 0.6826, P C
0.001). Furthermore, the degree of interstitial fibrosis as observed in the
renal biopsies showed a distinct positive correlation with tubular
dysfunction measured by the Re1C199"Tc-DMSA. These findings con-
firm the value of the Re1ClssmTeDMSA as a non-invasive test for the
degree of interstitial fibrosis in amyloid nephropathy and contribute to
a better understanding of the mechanism of renal function loss in renal
amyloidosis.
Renal and systemic effects of atrial natrinretic peptide (ANP) in
essential hypertension (EH): Preliminary results. W.M. T. Jonssen, PP.
de Jong, G.K. von der Hem, D. de Zeenw. Division of Nephrology,
State University Hospital, Groningen, The Netherlands. Synthetic
human ANP was infused during four hours at doses of 0.5 and 1.0
jig/mm in three patients with EH when they adhered to a diet with 200
mmnl NaCI, and at doses of 0.125, 0.25 and 0.5 jig/mm in balance on a
50 mmol NaCI diet. No effect on systemic blood pressure (BP) or even
a pressor response was observed on doses of 0.125 at low, and 0.5 at the
high sodium intake. The higher doses caused a distinct drop in BP.
Thus, a steep dose—response relation was observed. Interestingly, a
higher BP-respnnse was seen during low salt intake. BP decreased
mainly during the last two hours of infusion, sometimes with severe
hypotensive complaints. We, therefore, were limted to evaluation of the
renal effects in the first two hours of infusion. We focused on the
question whether renal hemodynamie, diuretic, and natriuretic re-
sponses coincided with BP responses. ERPF showed a marked de-
crease of about 10%, independent of sodium balance as well as of the
ANP dose. Changes in GFR were small, except for the 1 jig/mm dose
where a 10% increase was observed. At the 50 mmol NaCI intake, no
change in urine flow occurred at the 0.125 and 0.25 jig/mm doses,
whereas a twofold increase was seen at the 0.5 dose. At the high sodium
diet, urine volume increased about two times at both doses. Sodium
excretion showed a similar pattern as urine volume. Urinary sodium
increased 50% at the two lowest doses of ANP during the low sodium
diet. During all other infusions sodium excretion about doubled. We
conclude that ANP shows a steep dose—response effect on BP during
both high and low salt intake, with a higher sensitivity un the low diet.
Furthermore, ANP decreases ERPF independent of sodium status as
well as of the ANP dose. Diuretic and natriuretic responses are only
dose related at the low sodium status. We suggest that renal responses
to exogenous ANP precede the BP response. A nun-hypotensive dose
already elicits diuretic and natriuretic properties.
The influence of a high protein (HP) versus a low protein (LP) diet on
the kidney function in moderate to severe renal insufficiency. (i.H.
Schoap, H.J.G. Bib, TtH.R. Alferink, P.L. Oe, A.J.M. Donker,
Department of Internol Medicine, Free University, .4msterdom, The
Netherbonds. It has been suggested that renal reserve filtration capacity
is absent when GFR levels are below 60 ml/miu/1 .73 also has been
suggested, however, that early protein restriction in chronic renal
failure is beneticial by lowering hyperfiltrationin still functioning ncph-
rons, even when CJFR levels are below 60 ml/min/l.73 at2. We,
therefore, investigated the effect of four weeks of low protein diet (LP)
and, subsequently, of four weeks of high protein diet (HP) on kidney
function in 18 patients with moderate to severe renal failure (OFR =
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13-73 ml/min/l.73 M2), and compared these results with those in five
control patients (GFR = 12-73 mI/mm/I .73 M2) who did not change their
diet as indicated by their blood and urine urea values. GFR and ERPF
were measured simultaneously with 125I-iothalamate and '311-hippurate,
respectively.
GFR
(ml/min/l .73M2)
ERPF
(ml/min/1 .73M2)
LP HPLP HP
N = 18
N—S
42.2 20.6 469b 22.3
37.0±25.0 35.4±24.4
181 77 209 94
154± 103 146± 97
blood urea
(mmol/liter)
urea excretion
(mmol/24 hr)
LP HP LP HP
N = 18
N = 5
8.8 4.3 119b 5.9
11.5 4.5 13.2 4.0
195 60 3436 60
275 33 309 55
mean SD; a p < 0.005; b P < 0.001
The difference in GFR as induced by HP versus LP diet amounted to an
average of 10.6% in our test population. No significant change in GFR
was observed in the control group. We conclude from these results
thatGFR can also vary in moderate to severe renal insufficiency
depending on the amount of protein ingested. This indicates a possible
reinstatement of the renal reserve filtration capacity by a LP-diet, and
might explain the beneficial effect of protein restriction on the progres-
sion of chronic renal failure.
Plasma volume (PV) changes during acetate (Ac) and bicarbonate (Bc)
dialysis and the influence of left ventricular function. Leunissen KML,
Cheriex E, Janssen J, Teule J, Mooy JMV, van HooffJP, Department
of Internal Medicine, Cardiology and Nuclear Medicine, Academical
Hospital, Maastricht, The Netherlands. In two consecutive weeks, 12
chronic patients were studied during Ac and Bc. Dialysis parameters
such as UF were standardized. PV (I'25Alb), osmolality (Osm) and
colloid oncotic pressure (COP) were measured. Hemodynamic moni-
toring and echocardiography (M-mode) were done. During Ac, plasma
refilling was considerably worse compargd to Bc (Table) while Osm and
COP did not differ. During Ac compared to Bc there was a significant
increase in heart rate (HR) and a decrease in mean arterial pressure
(MAP) (Table). Cardiac function (fiber shortening velocity-VcF) in-
creased significantly (P < 0.005) during Ac and Bc respectively +0.21
and +0.25 circ/sec. Four patients wih a compromised left ventricular
function (VcF < 1.0 circ/sec) were studied separately: plasma refilling
after hr during Ac was very poor (VFM/VUFA. 0.9 3.2). It was
considerably better during Bc (77.0 9.2) and was almost as good as in
patients with a normal left ventricular function. Cardiac function
improved during Ac and Bc, but the improvement was more pro-
nounced during Be, respectively. VcF +0.14 0.09 and +0.25 0.02.
In conclusion, PV was considerably better preserved during Bc com-
pared with Ac. This difference is much more pronounced in patients
with a compromised left ventricular function. In those patients, Ac is
deleterious for PV balance.
Hr D VFM/VUFa LMAP HR
Ac 8.1 2.6 —13 4.1 +14.1 3.1°
2
Bc 91.0 86b +0.6 25b +6.1 1.4
Ac 37.1 9.6 —15 4.6 +14.3
Bc 79.0 6.2 —4.1 5.4 + 8.1 1.8
2
Ac
Bc
54.8 10.4
86.1 5.8°
—9.2 4.9
—2.9 4.4
+ 15.4
9.7
2.2
1.7
a extravascular fluid mobilization related to the ultrafiltration volume
b < 0.001
P < 0.01
d P < 0.05
Passenger leucocyte dependent prolonged rat renal allograft survival.
P.U.C. Van Breda Vriesman, G.D. Majoor, L. Nagelkerken,
Maastricht, The Netherlands. Well perfused rat kidneys contain at least
two sets of passenger leukocytes (PL): radiosensitive, immunocompe-
tent T lymphocytes (106 per I g) fixed and (5.l0) capable of migrating
out of a renal allograft and relatively fixed, radioresistant dendritic
cells. In this study we examined the effect of manipulation of the PL
population in the LEWIS (LEW) donor on the rejection of these
kidneys in unmodified and LEW-E tolerized Brown Norway (BN)
recipients. For this purpose LEW were 900 Rad X-irradiated 48 hr prior
to transplantation. X-irradiation of the donor caused a slightly pro-
longed LEW renal allograft survival (MTS 10 days in unmodified BN
recipients, control seven days). When BN recipients were LEW
erythrocyte—tolerant, markedly prolonged survival (>70 days) was
observed. This prolonged survival could be reduced by prior X-
irradiation of the donor kidney (MST 34 4) and was abolished
together (MST II 0.6) when 5.106 donor thoracic duct lymphocytes
were infused at the time of insertion of the X-irradiated LEW kidney
into the tolerized BN recipient. Ia positive dendritic—like cells residing
in the thoracic duct lymph caused this effect without breaking tolerance
to LEW-E. Passive transfer of 5.106 donor thoracic duct cells into
tolerized BN recipients of non X-irradiated LEW kidneys did not
influence survival. These results show that the markedly prolonged
survival of LEW kidneys in tolerized BN recipients requires the
presence of radiosensitive donor passenger leukocytes in the graft. Our
results suggest that this population is probably a non-mobile population
of donor T lymphocytes which exert their effect locally in the graft.
Pseudo Kaposi sarcoma: A distal complication of ciminobrescia arte-
riovenous fistula. AM. Bogaert, R. Vanholder, L. Dc Keyzer, A. Kint,
J. Dc Roose, S. Ringoir, Department of Nephrology, Dermatology and
Surgery, University Hospital, De Pintelaan, 185, 9000 Ghent, Belgium.
Pseudo Kaposi's sarcoma has been associated in most cases with an
underlying congenital arteriovenous fistula. Theoretically, this lesion
can be expected as well in relation with hemodialysis vascular accesses.
Nevertheless, this disease has only once been reported in conjunction
with Cimino—Brescia arteriovenous fistulas, and no attention has been
paid to the potential complication risks. Recently, we observed three
cases within a hemodialysis population of eighty patients. A biopsy was
performed in two of the three patients, confirming the preconceived
clinical diagnosis. This procedure was followed by local infection and
retarded healing of the wound, treated by antibiotics during several
weeks. In a third patient pseudo Kaposi's sarcoma was complicated by
an infected open wound and septicemia necessitating the administration
of iv. antibiotics. Fistulographic and/or Doppler evaluation revealed
venous outflow stenosis in only one case. After reconstruction (one
patient) or abandoning the fistula (two patients) correction of the lesions
was observed. It is concluded that pseudo Kaposi sarcoma can occur as
a distal complication of Cimino—Brescia arterio—venous fistulas. There
is a potential risk of serious complications when no corrective measures
are taken. The performance of a skin biopsy might be associated with
infection and delayed wound healing, so that it should only be obtained
in cases of doubt concerning the diagnosis.
Assessment of hyperoxaluria in patients with chronic renal failure.
B.G. Wolthers, S. Mel/er, T. Tepper, M. Hayer, Central Laboratory for
Clinical Chemistry and Department of Nephrology, University Hospi-
tal, Groningen, Groningen, The Netherlands. An eighteen—year—old
boy, dialysed twice a week because of chronic renal failure, was
suspected of having hyperoxaluria. In order to prove its presence,
plasma oxalate concentrations just before and at the end of dialyses
were measured as well as oxalate concentrations in hemodialysate at
various moments during dialysis. The obtained values were compared
with those derived from a group of 12 other patients, one of them known
of having primary hyperoxaluria type I. Oxalate concentrations in
plasma and hemodialysate of the known and suspected hyperoxaluric
patients were found to be similar and far above those obtained for the
remaining non-hyperoxaluric patients. It was concluded that a plasma
oxalate concentration above 100 /Lmol/liter before dialysis and above 25
jzmol/liter after dialysis in combination with an oxalate concentration in
hemodialysate above 25 mol/liter at the beginning and above 10
mol/liter at the end of dialysis, is indicative for hyperoxaluria. From
the data obtained for the hemodialysate samples the amount of removed
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oxalate during dialysis could be calculated. For patients dialysed twicc
a week, this amount should he less than 2 minol in order to exclude
hyperoxaloria. Both the suspected as provcn hypcroxaluric patieot
showcd values well above this limit. In order to prove that our paticnt
had primary hypcroxaluria typc I his plasma glycollate concentration
was measured, which was nut cssentially different from that of the other
patients. However, primary hyperoxaluria typc I should oot be otled
out, as all dialyscd patients showed plasma glycollatc levels far below
those of oxalatc, whcrcas in pcrsons with normal renal function these
concentrations were approximately equal. Our results suggest, there-
fore, that in dialyzed patients a metabolic shift occurs.,rcsulting in more
conversion of glyoxalate to oxalate compared with normals making it
difficult to prove whethcr such a patient suffers of primary
hyperoxaluria type I.
Prognostic value of I cell subset ratios for renal graft survival in
patients on different immunosuppressive regimens. F.C. Henny, L.C.
Paul, A. tan Es, P.J. Ol/an.s, W.M. Baldwin, hf. Thnke, L.A. van Es,
Departments of Nephrologv and CEo- and Histaciiemnistry, University
Hospital, Leiden, The Netherlands. Previously we reported that the
pretransplanl and pre-rejeetion OKT4/OKT8 ratio can be used to
predict renal allograft survival. Patients on azathioprine (Aza) and low
dose steroids (St) with a pretransplant ratio 1.6 exhibited a six month
graft survival of 33% compared with 79% for those with a ratio> 1.6 (P
= 0.02). Furthermore, 100% of the rejection episodes treated with high
doses uf prednisone for patients with a prerejection ratio 1.6 were
irreversible in comparison with only 10% for patients with a nilion >1.6
(P C 0.001). In the present study. we investigated the prognostic value
of the OKT4/OKT8 ratio for patients who received rabbit antithymo-
cyte globulin (RATh) as anti-rejection therapy or cyclospodn A (CsA)
as basic immunosuppressive therapy. No correlation was found be-
tween the pretransplant OKT4/OKT8 ratio and six month graft survival
for either treatment group because of an improved graft survival among
patients with a pretransplant ratio c 1.6 (78% for patients who received
RATG and 85% for CsA-treated patients). For ALa-treated patients,
rejection episodes with OKT4/OKT8 ratio 1.6 that were treated with
RATO were reversible in in 78%) of the cases, whereas among CsA-
treated patients, rejection episodes treated with high doses of predni-
sone were reversible in 72% of the cases. No significant differences in
graft survival or reversibility of rejection episodes in patients with a
pretransplant or prcrejcction OKT4/OKT8 ratio >1.6 were found.
Furthermore, in both the CsA and the Aza-treated patients (with or
without RATO), the OKT4/OKT8 ratio had significantly decreased
three months after transplantation. This decrease was associated with
cytomegalovirus infections rather than the type of immunosuppressive
therapy.
Treatment of NZB/W female mice with prednisone (PDN),
cyclophosphainide ICY) or total lymphoid irradiation (ILL). M. Waer, B.
Van Daintne, M. van der Sclioeren, P. Michielsen, M. i/andepntte.
Unh'ersity of Leaven, Belgium. Nine to 11 month old NZB/W mice with
high grade Inpus—like glomerulonephritis (proteinoria > 3 g/liter) re-
ceived daily injections of PDN (5mg/kg; N '— 18), weekly pulses of CY
(25 mg/kg; N — 25) or 17 daily fractions of 2 Dy of TLI (N — 26) or no
treatment (Control, (Con; N — 10). At three nsooths after the start of
therapy, none of 10 Con and only three of 18 PDN mice survived, none
of the latter showing remission (proteinuria C I g/liter). CY therapy was
efficient since 57% survival was obtained (P < 0.01 vs Con) with
remissionin 80% of Ihe surviving mice. TLI was even more effective
(survival 87% P <0.01 vs. CY and 94%/remission in surviviog animals).
Higher mortality in CY vs. '[LI was due to lymphoma and infections.
Both TLI and CY provoked a significant decrease of the activity index
and a stabilization of the chronicity index on renal biopsy. Tm-
munofluorescenee (IF) remained strongly positive in both groups.
Anti-DNA antibodies (ab) were significantly decreased only by CY and
not by iLl. In conclusion, bath ILl and CY pulse therapy are etfeetive
in treating NZB/W glomernlonephritis, but TLI is associated with less
side effects. The finding of persistently high anti-DNA ab together wih
strongly positive IF despite remission in [LI treated mice suggests that
beside anti-DNA antibodies, other mechanisms (cellular?) are also
involved io NZB/W lupns—like disease.
Hemodialysis biocompatihility: Dialyzer, dialysate and patient depen-
dent responses. F. A.A. de Jonge. C. J. Kalknian, M. R. Daha, and M.
J. fvnhé. Alkmoaar Medical Centre and University Hospital Leiden, The
Netherlands. The effect of cuprophane (CU) and cellulose acetate (CA)
membranes and of acetate (AC) and bicarbonate (BC:) dialysate on
neutrophil count, arterial PO: and complement activation (CAC) were
studied prospectively in three groups of six chronic hemodialysis
patients each. In each group, patients were studied during four dialysis
sessions (2 x CU, 2 x CA). Patients in group I received AC dialysis
only. Patients in group 2 first received 1 hour of isolated ultrafiltration
(UF) prior to AC dialysis. Patients in group 3 received BC dialysis only.
Within the first 30 minutes, nentropenia occurred in all three groups,
being signiticantly greater for CU than CA. 1-lypoxemia occurred only
during AC dialysis (group I; group 2, after U F) arid did not occur during
BC dialysis (group 3) or tJF (group 2). CAC, as measured by C3d levels,
occurred to a variable degree in all three groups, but no significant
difference between CU and CA was found. Analysis of variance
identified two patient subgroups: one group (N = 4) with rebound
leucocytosis after 60 nsinntes of dialysis on CU with relatively high
CAC, and a second group (N — 3) without rebound leucocytosis on CU
with substantially less CAC. Furthermore, in the first group, nentrophil
counts after 60 minutes of dialysis on CA were more depressed than in
the second group. We conclude that: (I) neulropenia and hypoxernia are
independent phenomena, the first membrane, the second dialysate
dependent; (2) individual (as yet unknown) patient factors influence the
neutrophil response and possibly CAC to a larger degree that hitherto
assumed.
Renal biopsy findings in 65 children with isolated hematuria. C.H.
Sclirhder, CM. Bontemps, K.J. Asstnann, f.M. Foidart, J.H.
Sehuurmans Stekhoven, J.H. Veerkomnp, L.A. Monnens, Depart oments
of Pediatrics, Pathology and Biochemistry, St. Rodhoud hospital,
University of' Nijmegen, The Netherlands, and Dept. of Obstetrics,
Bavibre Hospital, University of Liege, Belgium. It remains Controver-
sial point that isolated hematuria in childhood should he investigated by
renal biopsy involving all available techniques. To elucidate this point,
a renal biopsy was performed in 65 children with isolated hematuria
persisting for at least one year. The renal biopsy was studied by light
microscopy, immnnofluorescence and eleetronmieroscopy. In all these
children glonierular filtration was normal. Proteinuria, hypercalcioria,
and hypertension were absent. In 14 children the diagnosis of IgA
nephropathy was made, in eight children the diagnosis of Alport
syndrome and in five children the diagnosis of post-infectious glomer-
olonephritis. Thirty—three children were classified as having benign
hematoria. Over half of these eases appeared familial. By electron-
microscopy all Alport patients showed typical findings: diffuse or focal
thickening and splitting of the glomernlar basement membrane ((IBM),
irregular alternation of thick, thin and normal OHM. In benign
hematuria GBM was thin (<:250 nm) over more than 50% of its
measured length in half of the studied children. Smaller percentages
were present in the others. Biopsies of children suffering from Alport
syndrome (6) and benign hematoria (6) were investigated by im-
munufluorescence using specific anti-OHM component antisera
(collagen IV. laminin, fibronectin, proteoglycan and Ooodpasture) and
compared with results obtained in biopsies from children with nephrotic
syndrome and minimal lesions. Only the activity of antieollagen IV was
slightly dinsinished in benign hemainria and Alport syndronie. The
Ooodpast ore antiserum gave variable results in Alport syndrome. A
positive immnnofloorescence was always present in benign hemaluria.
Studies by immnnofluorescence and electronmicroseopy are required to
differentiate isolated hematnria in childhood. They are important for the
prognosis of these children and for genetic connseling. Abnormal
histology was present in 62 out of 65 children in contrast with the results
of the unique similar study of Trachtman et al., who were unable to
detect abnormalities in 33 out of 76 children.
The bemmelicial effect of indomethacin on final renal outcome in ne-
phrotic patients. 1? Vriesendorp. P F de .fong, W J Shader, D de Zeeuw.
A J M Donker, G K van cler hem. Division of nephirobogv, University
Hospital, Grmsningen, the Netherlands. 'lu study the influence rsf
indomethaeiu as antiproteinuric agent on renal function decline and
final remmal outconic in nephrotic patients, a retrospective study was
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undertaken. One hundred and fourteen patients were identified with a
proteinuria of more than 3 g per day and with a diagnosis membranous
glomerulopathy, focal glomerulosclerosis, or membranoproliferative
glomerulonephritis out of the renal biopsy records from 1968 to 1984.
Those diagnosis groups were selected because they were not routinely
treated with corticosteroids. Sixteen patients were excluded because of
follow—up less than six months. Fifty—eight patients had been treated
with indomethacin for at least half a year, while the other forty patients
acted as their untreated controls. As assessed by log rank analysis,
renal survival was significantly superior in the indomethacin—treated
patients over the untreated patients. At ten years follow-up, 31 percent
of the treated and 66 percent of the untreated patients needed dialysis (P
< 0.05). Renal function decline was assessed by creatinine doubling
time. Indomethacin treatment, serumcreatinine, mean arterial pressure,
proteinuria, serum albumin, age, sex, and diagnosis were evaluated for
their prognostic significance by log rank analysis of the creatinine
doubling life tables. In this univariate analysis, proteinuria and diagno-
sis influenced the rate of renal function decline significantly. Heavy
proteinuria and membranoproliferative glomerulonephritis were asso-
ciated with a rapid doubling of serum creatinine. In the subset of
patients with a serum creatinine less than 110 mol per liter, indometh-
acm delayed creatinine doubling significantly. In this retrospective
study the use of indomethacin as antiproteinuric agent appeared to have
a beneficial effect on long—term renal survival in nephrotic patients.
This hold especially true in patients with a serum creatinine less than
110 mol per liter at the start of treatment.
Dysplasia and hypopiasia in refluxing kidneys of patients with renal
failure. B. van Damme, R. Oyen, Y. van Renterghem Leuven, Belgium.
Reflux nephropathy is an important cause of renal failure. In refluxing
kidneys different scars have been described: pyelonephritic scars,
reflux scars, and dysplasia or hypoplasia. Dysplasia is defined by the
presence of 'primitive' tubules surrounded by concentric loose connec-
tive tissue. Hypoplasia is defined by the absence of normally formed
nephrons or the evident scarcity of nephrons in a segment of the kidney.
In 21 patients with radiologically proven reflux of at least grade II, one
or both kidneys removed as a pretransplant procedure were retrospec-
tively analysed for the presence of these scars. Hypoplasia and/or
dysplasia was present in 17 patients, combined with reflux scars in 13,
pyelonephritic scars in one, and reflux and pyelonephritic scars in two.
Only four patients did not have features of dysplasia or hypoplasia.
These data suggest that congenital malformation of the kidney may be
a major factor in the eventual destruction of renal structure and
function. This might also explain why reparative surgery on refluxing
kidneys does not alter the outcome of the reflux nephropathy and why
new scars are only seldom found during follow—up of reflux nephrop-
athy.
Recurrent peritonitis in CAPD: Survival and growth of bacteria within
human mononuclear phagocytes as a possible mechanism. H. van
Bronswijk, H.J. Bos, H.A. Verbrugh, P.L. Oe, J. Verhoef, A.J.M.
Donker, Free University Hospital, Amsterdam, and State University of
Utrecht, The Netherlands. Patients treated by CAPD may suffer from
frequent bouts of peritonitis, frequently due to Staphylococcus epider-
midis (SE). Recurrence or persistence of SE infection may reflect
intraleukocytic sequestration of bacteria that remain viable inspite of
antimicrobial therapy. We studied survival and growth of SE after
phagocytosis by human polymorphonuclear leukocytes (PMN),
monocytes (MN) and peritoneal macrophages (PMO). PMN, MN and
PMO ingested equal numbers of opsonized SE: from the 5 x 106 SE
colony forming units (CFU) inoculum, 1.0-3.5 X IIV SE cfu remained
viable after one hour incubation indicating comparable initial killing
rates of SE in PMN, MN and PMO. Electronmicroscopy (EM) showed
intact as well as desintegrating SE within phagolysosomes. Subse-
quently, phagocytes were washed to remove free SE and incubated for
18 hours in the presence of minimal inhibitory concentrations of
cefamandol (CF), clindamycmn (CL), or rifampicin (RF). In the presence
of CF PMN-associated SE cfu decreased 7 2 (mean SEM) fold; in
contrast, MN and PMO-associated SE cfu increased 17 6 fold and 26
9 fold, respectively. In the presence of CL or RF, however, SE cfu
decreased significantly in all three types of phagocytes. EM at 18 hours
revealed increased numbers of SE in MN, but not in PMN incubated
with CF. We conclude that SE survives and grows in human MN and
PMO, but not in PMN. Secondly, the ability to suppress intracellular
growth of SE seems to be an important requirement for optimal
antibiotic treatment of SE infections.
Important role for mannitol in the prevention of acute renal insuffi.
ciency after cadaveric transplantation. P.L.J. van Valenberg, A.J.
Hoitsma, R.G.W.L. Tiggeler, J.H.M. Berden, H.J.J. van Lier, RAP.
Koene, Division of Nephrology, Sint Radboudziekenhuis, N(jmegen.
With its incidence at about 40%, acute renal insufficiency (ARI) is a
major problem after cadaveric renal transplantation. We have previ-
ously shown that with moderate hydration (2.5 liters) of the recipient
together with rapid infusion of 250 ml Mannitol 20% (MA) just before
clamp removal, the incidence of AR! decreased to below 10%. Admin-
istration of MA without hydration was not effective. In a prospective
randomized trial we have now investigated whether hydration without
MA is sufficient to prevent ARI. We defined AR! as a urine volume of
less than 400 ml per 24 hours. All recipients received moderate
hydration. Patients were randomly treated with either cyclosporin (CS)
or azathioprine (AZ). In both treatment groups, recipients were ran-
domized to treatment with either MA or placebo (250 ml glucose 5%,
GL). The statistical method used to allocate patients made balance in
advance for sex, age of the donor and the recipient, DR mismatches,
number of previous transplantations, DRW6 antigen, anti-lymphocyte
antibodies, and total cold ischemia time. In the four treatment groups,
factors concerning the donors (diuresis and blood pressures before
nephrectomy, and serum creatinine) and the recipients (total amount of
fluid infused during the operation, per operative blood pressures,
method of kidney replacement therapy before transplantation, original
kidney disease, and serum urea) were the same. In the CS-group, the
percentage of ARI was significantly lower in MA-treated (N = 32) than
in GL-treated patients (N = 32) (9 vs. 34%, P < 0.05). In the AZ-group
the percentage of ARI was also lower in MA-treated (N = 33) than in
GL-treated patients (N = 34) (18 vs. 44%, P < 0.05). Overall evaluation
of AR! in both groups showed a significant difference in favour of
MA-treatment (P = 0.001). Thus, moderate hydration and administra-
tion of 250 ml mannitol 20% just before arterial clamp release are both
indispensable for optimal prevention of AR! after cadaveric transplan-
tation.
The influence of cyclosporine on renal allograft survival and function.
F.C. Henny, A.A.M. Kootte, J.H. van Bockel, W.M. Baldwin, J.
Hermans, B. Bos, L.A. van Es, L.C. Paul, Departments ofNephrology,
Surgery, and Medical Statistics, University Hospital, Leiden, The
Netherlands. To study the effectiveness and nephrotoxic side-effects of
Cyclosporin A (CsA) in renal transplant recipients, a prospective
randomized trial was designed in which CsA was compared with
Azathioprine (Aza). Fourty patients had entered in each treatment
group; in the CsA group, 18 were randomly selected for conversion to
Aza after three months. The one—year graft survival in CsA-treated
patients was 87% compared with 66% in the Aza-treated patients (P =
0.033). The incidence of one or more rejection treatments was 75% in
the Aza-treated group compared with 45% in the CsA group (P 0.01).
The incidence of primary non-functioning kidneys, cytomegalovirus
infections, hypertension, and degree of proteinuria did not differ in the
two treatment groups. At three months the mean endogenous creatinine
clearance was 42 2 mI/mm (mean SEM) in the CsA-treated group
compared with 56 4 mI/mm in the Aza group (P < 0.001), whereas at
six months the mean creatinine clearances for both the converted and
non-converted CsA-treated patients did not differ from that found for
the Aza-treated group. At one year, the mean creatinine clearances
found for CsA-treated patients who were converted to Aza and for
those who remained on CsA-therapy were higher than in the Aza-
treated patients (62 7 and 55 3 ml/min, respectively, vs. 50 6
mI/mm; P < 0.05). Furthermore, the increment in creatinine clearances
observed after conversion from CsA to Aza showed a linear relation-
ship (r = 0.9061) with the CsA trough levels before discontinuation of
the drug. This indicates that CsA treatment induces a dose—dependent,
nephrotoxic side effect which is probably reversible.
